AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · IEX Real-Time Price · USD

3.780

-0.060 (-1.56%)

At close: Apr 30, 2024, 4:00 PM

3.820

+0.040 (1.06%)

Pre-market: May 1, 2024, 7:14 AM EDT

AbCellera Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	1,107	1,657	2,898	4,027	10,702	-	-
Market Cap Growth	-	-42.83%	-28.02%	-62.37%	-	-	-
Enterprise Value	392	943	2,063	3,315	10,112	-1	-7
PE Ratio	-11.32	-11.32	18.28	26.24	89.99	-	-
PS Ratio	29.10	43.57	5.97	10.73	45.90	-	-
PB Ratio	0.96	1.44	2.35	3.93	12.89	-	-
P/FCF Ratio	-13.71	-13.71	14.02	21.63	822.15	-	-
P/OCF Ratio	-37.76	-37.76	10.45	16.46	471.66	-	-
EV/Sales Ratio	10.32	24.79	4.25	8.84	43.37	-0.13	-0.79
EV/EBITDA Ratio	-6.58	-6.58	7.58	14.02	59.51	9.47	-4.87
EV/EBIT Ratio	-5.42	-5.42	8.63	15.13	61.41	0.73	-13.44
EV/FCF Ratio	-7.80	-7.80	9.98	17.81	776.79	1.13	4.02
Debt / Equity Ratio	0.06	0.06	0.06	0.04	0.00	0.59	0.30
Debt / EBITDA Ratio	-0.50	-0.50	0.28	0.15	0.02	-39.26	2.39
Debt / FCF Ratio	-0.59	-0.59	0.37	0.20	0.29	-4.67	-1.98
Quick Ratio	6.86	6.86	8.03	7.53	7.80	1.37	1.84
Current Ratio	7.33	7.33	8.67	7.71	7.86	1.60	2.36
Asset Turnover	0.03	0.03	0.31	0.32	0.45	0.52	-
Interest Coverage	-	-	-	-	24.17	-9.58	2.46
Return on Equity (ROE)	-12.40%	-12.40%	12.90%	15.70%	28.30%	-20.20%	-
Return on Assets (ROA)	-9.70%	-9.70%	10.10%	12.90%	23.10%	-9.80%	-
Return on Capital (ROIC)	-19.39%	-19.39%	10.96%	13.48%	14.09%	-25.20%	-5.00%
Earnings Yield	-13.23%	-8.84%	5.47%	3.81%	1.11%	-	-
FCF Yield	-10.92%	-7.29%	7.13%	4.62%	0.12%	-	-
Buyback Yield / Dilution	8.15%	8.15%	1.09%	-20.96%	-73.88%	11.68%	-
Total Shareholder Return	8.15%	8.15%	1.09%	-20.96%	-73.88%	11.68%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).